Intellia Therapeutics Earnings Surprises image   This NTLA earnings surprises page last updated 3/11/2024
Intellia Therapeutics Earnings Surprises Chart
PeriodExpectedActualSurprise
Q3 2023 -1.50 -1.38 +0.12 (-8%)
Q2 2023 -1.32 -1.40 -0.08 (+6%)
Q1 2023 -1.40 -1.17 +0.23 (-16%)
Q4 2022 -1.39 -1.40 -0.01 (+1%)
Q3 2022 -1.28 -1.49 -0.21 (+16%)
Q2 2022 -1.31 -1.33 -0.02 (+2%)
Q1 2022 -1.10 -1.96 -0.86 (+78%)
Q4 2021 -0.94 -1.09 -0.15 (+16%)
Q3 2021 -0.84 -0.97 -0.13 (+15%)
Q2 2021 -0.63 -1.01 -0.38 (+60%)
Q1 2021 -0.67 -0.69 -0.02 (+3%)
Q4 2020 -0.60 -0.69 -0.09 (+15%)
Q3 2020 -0.59 -0.47 +0.12 (-20%)
Q2 2020 -0.69 -0.61 +0.08 (-12%)
Q1 2020 -0.44 -0.63 -0.19 (+43%)
Q4 2019 -0.56 -0.57 -0.01 (+2%)
Q2 2019 -0.60 -0.56 +0.04 (-7%)
Q1 2019 -0.58 -0.49 +0.09 (-16%)
Q3 2018 -0.49 -0.53 -0.04 (+8%)
Q2 2018 -0.55 -0.52 +0.03 (-5%)
Q1 2018 -0.58 -0.51 +0.07 (-12%)
Q4 2017 -0.44 -0.61 -0.17 (+39%)
Q3 2017 -0.50 -0.44 +0.06 (-12%)
Q2 2017 -0.42 -0.45 -0.03 (+7%)
Q4 2016 -0.23 -0.31 -0.08 (+35%)
Q2 2016 -0.16 -0.36 -0.20 (+125%)
Intellia Therapeutics Revenue Surprises Chart
PeriodExpectedActualSurprise
Q3 2023 12.45M 11.99M -0.46M (-4%)
Q2 2023 13.95M 13.59M -0.36M (-3%)
Q1 2023 11.83M 12.61M +776000 (+7%)
Q4 2022 11.33M 13.57M +2.24M (+20%)
Q3 2022 11.31M 13.27M +1.96M (+17%)
Q2 2022 9.42M 14.03M +4.61M (+49%)
Q1 2022 8.54M 11.25M +2.71M (+32%)
Q4 2021 8.26M 12.85M +4.59M (+56%)
Q3 2021 8.66M 7.20M -1.46M (-17%)
Q2 2021 11.89M 6.55M -5.34M (-45%)
Q1 2021 8.57M 6.45M -2.12M (-25%)
Q4 2020 14.09M 6.59M -7.50M (-53%)
Q3 2020 15.58M 22.22M +6.64M (+43%)
Q2 2020 8.54M 16.26M +7.72M (+90%)
Q1 2020 18.14M 12.92M -5.22M (-29%)
Q4 2019 9.94M 10.94M +996000 (+10%)
Q2 2019 7.11M 11.12M +4.01M (+56%)
Q1 2019 7.63M 10.43M +2.80M (+37%)
Q3 2018 11.58M 7.41M -4.17M (-36%)
Q2 2018 6.63M 7.68M +1.05M (+16%)
Q1 2018 6.27M 7.47M +1.20M (+19%)
Q4 2017 6.85M 6.67M -0.18M (-3%)
Q3 2017 5.88M 7.32M +1.44M (+24%)
Q2 2017 5.83M 5.92M +87000 (+2%)
Q4 2016 6.10M 5.63M -0.47M (-8%)
Q2 2016 5.81M 4.21M -1.60M (-28%)
Quotes delayed 20 minutes

Email EnvelopeFree NTLA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Fortrea Holdings (FTRE): 3/11/2024 7:00 AM
Overseas Shipholding Gr (OSG): 3/11/2024 7:30 AM
Genie Energy (GNE): 3/11/2024 7:30 AM
Curis (CRIS): 3/11/2024 8:00 AM
Ocular Therapeutix (OCUL): 3/11/2024 After close
Ranpak Hldgs (PACK): 3/11/2024 After close
NET Power (NPWR): 3/11/2024 After close
Heritage Insurance Hldgs (HRTG): 3/11/2024 After close
Assertio Holdings (ASRT): 3/11/2024 After close
Amylyx Pharma (AMLX): 3/11/2024 After close

More from the Next Earnings Dates Calendar

Earnings History:

Cue Biopharma (CUE): 3/9/2024 After close
Ovid Therapeutics (OVID): 3/8/2024 8:00 AM
America's Car-Mart (CRMT): 3/8/2024 8:00 AM
Sigmatron International (SGMA): 3/8/2024 8:00 AM
XOMA (XOMA): 3/8/2024 7:30 AM
Dixie Gr (DXYN): 3/8/2024 7:00 AM
Genesco (GCO): 3/8/2024 6:50 AM
Nine Energy Service (NINE): 3/7/2024 5:00 PM
Ring Energy (REI): 3/7/2024 After close
Team (TISI): 3/7/2024 After close

More from the Earnings History archive
Intellia Therapeutics (NTLA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NTRA Historical Earnings
NTRB Historical Earnings
NTUS Historical Earnings
NURO Historical Earnings
NUVA Historical Earnings
NUVB Historical Earnings
NUVL Historical Earnings
NUWE Historical Earnings
NVAX Historical Earnings
NVCT Historical Earnings
On this page we presented the NTLA earnings surprises information for Intellia Therapeutics, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on NTLA (or any other given stock) can benefit from researching all of the Intellia Therapeutics past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Intellia Therapeutics earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about NTLA's next earnings report. In your continued research on Intellia Therapeutics we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for NTLA. Thanks for visiting, and the next time you need to research NTLA earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: Funds Holding FNDE, Top Ten Hedge Funds Holding EMSO, SITM Options Chain.

 

Intellia Therapeutics Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.